Apoptosis induced by TGF-β1 in Burkitt's lymphoma cells is caspase 8 dependent but is death receptor independent

Journal of Immunology

Volumn 165, Issue 5, 2000, Pages 2500-2510

  Inman, G J ^a   Allday, M J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 2; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; FAS ANTIGEN; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA1;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL SURFACE; ENZYME DEGRADATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEADY STATE;

EID: 0034284209     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.5.2500     Document Type: Article

References (68)

1. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis
2. Death receptors: Signalling and modulation
3. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis
4. Apoptosis control by death and decoy receptors
5. Cytochrome c and dATP-dependent formation of Apaf-l/caspase-9 complex initiates an apoptotic protease cascade
6. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9
7. BCL-2 gene family and the regulation of programmed cell death
8. TGF-β signal transduction
9. TGF-β signalling from cell membrane to nucleus through SMAD proteins
10. Regulation of immnune responses by TGF-β
11. Epstein-Bare virus mediates a switch in responsiveness to transforming growth factor, type β, in cells of the B cell lineage
12. 1 to S transition, but not activation of human B lymphocytes
13. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes
14. Transforming growth factor-β1: Differential effects on multiple myeloma versus normal B cells
15. Further studies of tile role of transforming growth factor-β in human B cell function
16. Transforming growth factor-β suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA
17. Influence of transforming growth factor-β (TGF-β) on the immunoglobulin production by EBV-infected B cell cultures
18. Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete irmnunoglobulin
19. TGF-β1 and cyclic AMP promote apoptosis in resting human B lymphocytes
20. Characterization of transforming growth factor-β1 induced apoptosis in normal human B cells and lymphoma B cell lines
21. Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-β
22. Transforming growth factor-β1 cooperates with anti-immunoglobulin for the induction of apoptosis in group 1 (biopsy-like) Burkitt lymphoma cell lines
23. Repression of apoptosis in human B-lymphoma cells by CD40-ligand and Bcl-2: Relationship to the cell-cycle and role of the retinoblastoma protein
24. Transforming growth factor-β-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-X(L) down-regulation
25. Role of caspases and possible involvement of retinoblastoma protein during TGF-β-mediated apoptosis of human B lymphocytes
26. Resistance to TGF-β1 correlates with a reduction of TGF-β type 11 receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines
27. Immediate early up-regulation of bax expression by p53 but not TGF β1: A paradigm for distinct apoptotic pathways
28. Transforming growth factor β1 induces apoptotic cell death in cultured human gastric carcinoma cells
29. Coordinated regulation of apoptosis and cell proliferation by transforming growth factor β1 in cultured uterine epithelial cells
30. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1
31. Transforming growth factor-β1 induces apoptosis through down-regulation of c-myc gene and overexpression of p27(Kip1) protein in cervical carcinoma
32. Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-β in human normal lung epithelial cells
33. FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b
34. Mammalian cells express two differently localized Bag-1 isoforms generated by alternative translation initiation
35. 1-arrested cells
36. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
37. Flow cytometric methods of analyzing apoptotic cells
38. 2/M when it is transactivation defective
39. Involvement of caspase family proteases in transforming growth factor-β-induced apoptosis
40. Processing/activation of CPP32-like proteases is involved in transforming growth factor β1-induced apoptosis in rat hepatocytes
41. ICE-like protease (caspase) is involved in transforming growth factor β1-mediated apoptosis in FaO rat hepatoma cell line
42. Restoration of transforming growth factor β signaling pathway in human prostate cancer ceils suppresses tumorigenicity via induction of caspase-1-mediated apoptosis
43. Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis: Evidence for involvement of caspase-7
44. The pathogenesis of Burkitt's lymphoma
45. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses ceil cycle arrest and accelerates apoptosis
46. Induction of apoptosis in fibroblasts by c-myc protein
47. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced
48. Apoptosis in Burkitt lymphoma cells is driven by c-myc
49. Expression of the APO-I antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype
50. Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis
51. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apol, and DR3 and is lethal prenatally
52. TNF-α inhibits anti-IgM-mediated apoptosis in Ramos cells
53. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95
54. Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis
55. Degradation of retinoblastoma protein in tumor necrosis factor- and CD95-induced cell death
56. Transforming growth factor-β1 abrogates Fas-induced growth suppression and apoptosis of murine bone marrow progenitor cells
57. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: Modulation by cytokines
58. Transforming growth factor β1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via down-regulation of c-Myc
59. Endogenous expression of transforming growth factorβ1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model
60. Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis
61. B cell apoptosis triggered by antigen receptor ligation proceeds via a novel caspase-dependent pathway
62. Caspase inhibitor BD-fmk distinguishes transforming growth factor β-induced apoptosis from growth inhibition
63. Transforming growth factor β induces caspase 3-independent cleavage of αlI-spectrin (α-fodrin) coincident with apoptosis
64. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release
65. TGF β1 inhibits NF-κB/Relactivity inducing apoptosis of B cells: Transcriptional activation of IκBα
66. B cell proliferation in follicles, germinal centre formation and the site of neoplastic transformation in Burkitt's lymphoma
67. Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2
68. Factors modifying survival pathways of germinal center B cells: Glucocorticoids and transforming growth factor-β, but not cyclosporin A or anti-CD19, block surface immunoglobulin-mediated rescue from apoptosis